LogicBio Therapeutics, Inc. Net Income
LogicBio Therapeutics, Inc. reported Net Income of -$5.78 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2022-11-14
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$5.78M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2022-06-30 was -$5.04M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2022-03-31 was -$6.66M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2021-12-31 was -$9.06M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2021 was -$40.03M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2020 was -$32.62M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2019 was -$40.13M.
- LogicBio Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2017 was -$5.79M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$5.78M 10-Q · filed 2022-11-14 | -$10.82M derived: sum of 2 quarters · filed 2022-11-14 | -$17.48M 10-Q · filed 2022-11-14 | -$26.54M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$5.04M 10-Q · filed 2022-11-14 | -$11.71M 10-Q · filed 2022-08-15 | -$20.77M derived: sum of 3 quarters · filed 2022-11-14 | -$30.95M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | -$6.66M 10-Q · filed 2022-11-14 | -$15.72M derived: sum of 2 quarters · filed 2022-11-14 | -$25.91M derived: sum of 3 quarters · filed 2022-11-14 | -$36.41M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | -$9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | -$19.25M derived: sum of 2 quarters · filed 2022-11-14 | -$29.75M derived: sum of 3 quarters · filed 2022-11-14 | -$40.03M 10-K · filed 2022-03-04 |
| 2021-09-30 | -$10.19M 10-Q · filed 2022-11-14 | -$20.68M derived: sum of 2 quarters · filed 2022-11-14 | -$30.97M 10-Q · filed 2022-11-14 | -$37.87M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$10.50M 10-Q · filed 2022-11-14 | -$20.78M 10-Q · filed 2022-08-15 | -$27.68M derived: sum of 3 quarters · filed 2022-11-14 | -$35.72M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-03-31 | -$10.28M 10-Q · filed 2022-11-14 | -$17.18M derived: sum of 2 quarters · filed 2022-11-14 | -$25.22M derived: sum of 3 quarters · filed 2022-11-14 | -$33.45M derived: sum of 4 quarters · filed 2022-11-14 |
| 2020-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | -$14.94M derived: sum of 2 quarters · filed 2022-03-04 | -$23.17M derived: sum of 3 quarters · filed 2022-03-04 | -$32.62M 10-K · filed 2022-03-04 |
| 2020-09-30 | -$8.04M 10-Q · filed 2021-11-15 | -$16.27M derived: sum of 2 quarters · filed 2021-11-15 | -$25.72M 10-Q · filed 2021-11-15 | -$37.19M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$8.23M 10-Q · filed 2021-11-15 | -$17.68M 10-Q · filed 2021-08-09 | -$29.15M derived: sum of 3 quarters · filed 2021-11-15 | -$40.06M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | -$9.46M 10-Q · filed 2021-11-15 | -$20.92M derived: sum of 2 quarters · filed 2021-11-15 | -$31.84M derived: sum of 3 quarters · filed 2021-11-15 | -$41.89M derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | -$11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$22.38M derived: sum of 2 quarters · filed 2021-03-15 | -$32.43M derived: sum of 3 quarters · filed 2021-03-15 | -$40.13M 10-K · filed 2021-03-15 |
| 2019-09-30 | -$10.92M 10-Q · filed 2020-11-09 | -$20.97M derived: sum of 2 quarters · filed 2020-11-09 | -$28.66M 10-Q · filed 2020-11-09 | -$35.72M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$10.05M 10-Q · filed 2020-11-09 | -$17.75M 10-Q · filed 2020-08-10 | -$24.81M derived: sum of 3 quarters · filed 2020-11-09 | -$29.48M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-03-31 | -$7.70M 10-Q · filed 2020-11-09 | -$14.76M derived: sum of 2 quarters · filed 2020-11-09 | -$19.43M derived: sum of 3 quarters · filed 2020-11-09 | -$23.01M derived: sum of 4 quarters · filed 2020-11-09 |
| 2018-12-31 | -$7.06M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-05-11 | -$11.73M derived: sum of 2 quarters · filed 2020-05-11 | -$15.32M derived: sum of 3 quarters · filed 2020-05-11 | -$17.62M 10-Q · filed 2020-05-11 |
| 2018-09-30 | -$4.67M 10-Q · filed 2019-11-12 | -$8.26M derived: sum of 2 quarters · filed 2019-11-12 | -$10.56M 10-Q · filed 2019-11-12 | -$13.57M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$3.59M 10-Q · filed 2019-11-12 | -$5.89M 10-Q · filed 2019-08-13 | -$8.90M derived: sum of 3 quarters · filed 2019-11-12 | -$9.95M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-03-31 | -$2.30M 10-Q · filed 2019-11-12 | -$5.32M derived: sum of 2 quarters · filed 2019-11-12 | -$6.36M derived: sum of 3 quarters · filed 2019-11-12 | |
| 2017-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$4.06M derived: sum of 2 quarters · filed 2019-04-01 | -$5.79M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$1.04M 10-Q · filed 2018-12-03 | -$2.78M 10-Q · filed 2018-12-03 | ||
| 2017-06-30 | -$1.74M 10-Q · filed 2018-12-03 |